FISH Panel for Leukemic CTCL
- PMID: 27836797
- PMCID: PMC5419071
- DOI: 10.1016/j.jid.2016.10.037
FISH Panel for Leukemic CTCL
Conflict of interest statement
CONFLICTS OF INTEREST:
JW, JL, and MG are listed as inventors on a provisional patent filed on several probes reported herein.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5419071/bin/nihms835641f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5419071/bin/nihms835641f2.gif)
Similar articles
-
MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.J Invest Dermatol. 2018 Sep;138(9):2024-2032. doi: 10.1016/j.jid.2018.03.1500. Epub 2018 Mar 17. J Invest Dermatol. 2018. PMID: 29559342
-
Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.J Pathol. 2003 Nov;201(3):421-9. doi: 10.1002/path.1469. J Pathol. 2003. PMID: 14595754
-
Angioimmunoblastic lymphadenopathy-like T-cell lymphoma: cutaneous clinical onset with prominent granulomatous reaction.Am J Surg Pathol. 2003 May;27(5):699-700. doi: 10.1097/00000478-200305000-00015. Am J Surg Pathol. 2003. PMID: 12717256 No abstract available.
-
Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.Curr Treat Options Oncol. 2016 Jul;17(7):33. doi: 10.1007/s11864-016-0410-8. Curr Treat Options Oncol. 2016. PMID: 27262707 Review.
-
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.Dis Markers. 2016;2016:9602472. doi: 10.1155/2016/9602472. Epub 2016 Oct 16. Dis Markers. 2016. PMID: 27821903 Free PMC article. Review.
Cited by
-
FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes.JID Innov. 2023 Jun 14;3(5):100212. doi: 10.1016/j.xjidi.2023.100212. eCollection 2023 Sep. JID Innov. 2023. PMID: 37674691 Free PMC article.
-
Cutaneous T cell lymphoma.Nat Rev Dis Primers. 2021 Aug 26;7(1):61. doi: 10.1038/s41572-021-00296-9. Nat Rev Dis Primers. 2021. PMID: 34446710 Review.
-
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL.Blood Adv. 2020 May 26;4(10):2213-2226. doi: 10.1182/bloodadvances.2020001756. Blood Adv. 2020. PMID: 32437546 Free PMC article.
-
CD8+ mycosis fungoides palmaris et plantaris with peripheral blood involvement.JAAD Case Rep. 2020 Apr 30;6(5):434-437. doi: 10.1016/j.jdcr.2020.02.025. eCollection 2020 May. JAAD Case Rep. 2020. PMID: 32382639 Free PMC article. No abstract available.
-
Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.Yale J Biol Med. 2020 Mar 27;93(1):111-121. eCollection 2020 Mar. Yale J Biol Med. 2020. PMID: 32226341 Free PMC article. Review.
References
-
- Hidaka T, Nakahata S, Hatakeyama K, Hamasaki M, Yamashita K, Kohno T, et al. Downregulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood. 2008;112(2):383–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical